243 related articles for article (PubMed ID: 34685629)
1. N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.
Kim G; Lim S; Kim KD
Cells; 2021 Oct; 10(10):. PubMed ID: 34685629
[TBL] [Abstract][Full Text] [Related]
2. The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.
Lee KW; Lim S; Kim KD
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012631
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
4. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis.
Liu N; Wang L; Li X; Yang Q; Liu X; Zhang J; Zhang J; Wu Y; Ji S; Zhang Y; Yang A; Han H; Yao L
Nucleic Acids Res; 2008 Sep; 36(16):5335-49. PubMed ID: 18689861
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 is a novel p53-associated regulator of apoptosis in C6-originated astrocytes exposed to oxygen-glucose deprivation.
Li Y; Xu N; Cai L; Gao Z; Shen L; Zhang Q; Hou W; Zhong H; Wang Q; Xiong L
PLoS One; 2013; 8(2):e57130. PubMed ID: 23451161
[TBL] [Abstract][Full Text] [Related]
7. NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer.
Wei Y; Yu S; Zhang Y; Zhang Y; Zhao H; Xiao Z; Yao L; Chen S; Zhang J
Oncotarget; 2017 Apr; 8(17):29038-29047. PubMed ID: 28423695
[TBL] [Abstract][Full Text] [Related]
8. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
Kang F; Wang Y; Luo Y; Zhang Y
J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation.
Pan T; Zhang M; Zhang F; Yan G; Ru Y; Wang Q; Zhang Y; Wei X; Xu X; Shen L; Zhang J; Wu K; Yao L; Li X
Biochem Biophys Res Commun; 2017 Feb; 483(2):860-866. PubMed ID: 28069379
[TBL] [Abstract][Full Text] [Related]
10. NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells.
Wang L; Liu N; Yao L; Li F; Zhang J; Deng Y; Liu J; Ji S; Yang A; Han H; Zhang Y; Zhang J; Han W; Liu X
Cell Physiol Biochem; 2008; 21(1-3):239-50. PubMed ID: 18209490
[TBL] [Abstract][Full Text] [Related]
11. NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.
Park S; Oh SS; Lee KW; Lee YK; Kim NY; Kim JH; Yoo J; Kim KD
Cell Death Dis; 2018 Jan; 9(2):30. PubMed ID: 29348517
[TBL] [Abstract][Full Text] [Related]
12. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death.
Choi SC; Yoon SR; Park YP; Song EY; Kim JW; Kim WH; Yang Y; Lim JS; Lee HG
Exp Mol Med; 2007 Dec; 39(6):705-14. PubMed ID: 18160841
[TBL] [Abstract][Full Text] [Related]
13. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
[TBL] [Abstract][Full Text] [Related]
14. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
15. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
Liu J; Zhang J; Wang X; Li Y; Chen Y; Li K; Zhang J; Yao L; Guo G
Exp Cell Res; 2010 Jul; 316(12):1985-93. PubMed ID: 20206160
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo.
Li R; Yu C; Jiang F; Gao L; Li J; Wang Y; Beckwith N; Yao L; Zhang J; Wu G
PLoS One; 2013; 8(10):e76689. PubMed ID: 24146910
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers.
Hu W; Yang Y; Fan C; Ma Z; Deng C; Li T; Lv J; Yao W; Gao J
Apoptosis; 2016 Jun; 21(6):675-82. PubMed ID: 27113371
[TBL] [Abstract][Full Text] [Related]
18. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
19. N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway.
Wang J; Xie C; Pan S; Liang Y; Han J; Lan Y; Sun J; Li K; Sun B; Yang G; Shi H; Li Y; Song R; Liu X; Zhu M; Yin D; Wang H; Song X; Lu Z; Jiang H; Zheng T; Liu L
Hepatology; 2016 Nov; 64(5):1606-1622. PubMed ID: 27533020
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of TAT-NDRG2 recombinant protein and evaluation of its anti-proliferative effect on LNCaP cell line.
Farokhinejad F; Behbahani AB; Rafiei Dehbidi GR; Takhshid MA
Protein Expr Purif; 2017 Oct; 138():25-33. PubMed ID: 28711733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
